BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000118 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 10, 2026 |
| Document | View SEC Filing |
Transactions
12
Total Shares
80,000
Total Value
$5,748,666.24
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 10, 2026 | Sale | 14,201 | $71.80 | $1,019,657.36 | 701,485 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Feb 10, 2026 | Sale | 5,799 | $72.28 | $419,165.06 | 695,686 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Feb 10, 2026 | Sale | 14,040 | $71.80 | $1,008,006.01 | 4,504,407 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Feb 10, 2026 | Sale | 5,960 | $72.27 | $430,751.25 | 4,498,447 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Feb 11, 2026 | Sale | 7,806 | $70.69 | $551,795.99 | 687,880 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Feb 11, 2026 | Sale | 3,716 | $71.44 | $265,476.99 | 684,164 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Feb 11, 2026 | Sale | 4,484 | $72.64 | $325,695.34 | 679,680 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Feb 11, 2026 | Sale | 3,994 | $73.25 | $292,574.48 | 675,686 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Feb 11, 2026 | Sale | 7,860 | $70.70 | $555,705.93 | 4,490,587 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Feb 11, 2026 | Sale | 3,775 | $71.46 | $269,754.33 | 4,486,812 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Feb 11, 2026 | Sale | 4,404 | $72.65 | $319,938.27 | 4,482,408 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Feb 11, 2026 | Sale | 3,961 | $73.25 | $290,145.23 | 4,478,447 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details |